Literature DB >> 205351

Abnormal distribution of O-alkyl groups in the neutral glycerolipids from human hepatocellular carcinomas.

H J Lin, F C Ho, C L Lee.   

Abstract

The direct comparison of O-alkylglycerol composition in the neutral lipids fractions prepared from human hepatocellular carcinomas with that in corresponding preparations from nonneoplastic liver is reported. Tumor-bearing liver and noncancerous liver specimens were obtained either during surgery or at autopsy. Thirty different tissue specimens obtained from 18 cases were analyzed. Representative samples from each specimen were examined microscopically to confirm the pathological diagnosis. Gas chromatographic analysis of alkylglycerol derivatives showed that hexadecylglycerol, octadecylglycerol, and octadecenylglycerol were the principal components. Compared to the noncancerous liver, hepatocellular carcinomas contained higher proportions of hexadecylglycerol and lower proportions of both C18-glyceryl ethers. Associated with this change was an increase in the proportion of saturated to monoenic alkylglycerols. These abnormalities appeared to be more severe in the necrotic areas of the tumors. Higher concentrations of neutral alkyl glycerolipids and of cholesterol were found in the tumors; no differences between the two groups could be found in the levels of ether-linked phosphoglycerides, triglycerides, and lipid phosphorus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205351

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis.

Authors:  Jae Won Chang; Daniel K Nomura; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2011-04-22

Review 2.  Biosynthesis and biotransformation of ether lipids.

Authors:  H K Mangold; N Weber
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

3.  Antineoplastic activity of synthetic lysophospholipid analogs.

Authors:  W E Berdel
Journal:  Blut       Date:  1982-02

Review 4.  An update on the therapeutic role of alkylglycerols.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Mar Drugs       Date:  2010-08-05       Impact factor: 5.118

5.  Identification of lipidomic markers of chronic 3,3',4,4',5-pentachlorobiphenyl (PCB 126) exposure in the male rat liver.

Authors:  Izabela Kania-Korwel; Xianai Wu; Kai Wang; Hans-Joachim Lehmler
Journal:  Toxicology       Date:  2017-09-07       Impact factor: 4.221

6.  Tumorigenicity of cell lines with altered lipid composition.

Authors:  D S Roos; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  A reliable biomarker derived from plasmalogens to evaluate malignancy and metastatic capacity of human cancers.

Authors:  Rosina E Smith; Pablo Lespi; María Di Luca; Claudia Bustos; Fernando A Marra; María J T de Alaniz; Carlos A Marra
Journal:  Lipids       Date:  2007-11-29       Impact factor: 1.880

Review 8.  Orphan enzymes in ether lipid metabolism.

Authors:  Katrin Watschinger; Ernst R Werner
Journal:  Biochimie       Date:  2012-07-04       Impact factor: 4.079

9.  The ether lipid tumour marker in human liver with hepatocellular carcinoma.

Authors:  H J Lin; P C Wu; J C Ho
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

10.  Biochemical studies on cell fusion. I. Lipid composition of fusion-resistant cells.

Authors:  D S Roos; P W Choppin
Journal:  J Cell Biol       Date:  1985-10       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.